139 related articles for article (PubMed ID: 3192050)
1. [Diagnosis, course and outcome of myelodysplasias].
Riauzova LIu; Soloveĭ DIa; Iavorkovskiĭ LI; Iavorkovskiĭ LL; Grinberg LIa
Gematol Transfuziol; 1988 Aug; 33(8):19-23. PubMed ID: 3192050
[No Abstract] [Full Text] [Related]
2. [The comparative characteristics of the clinico-hematological indices in patients with different forms of myelodysplasias].
Pesotskaia LA
Lik Sprava; 1997; (2):59-62. PubMed ID: 9333486
[TBL] [Abstract][Full Text] [Related]
3. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
Di Giovanni S; Giallonardo P; Costa MP; Carducci P
Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
[No Abstract] [Full Text] [Related]
4. [Myelodysplastic syndromes: current diagnosis and classification].
Tsvetaeva NV; Zavadenko MA; Ol'shanskaia IuV; Glasko EN; Khoroshko ND
Ter Arkh; 2001; 73(4):62-6. PubMed ID: 11494452
[No Abstract] [Full Text] [Related]
5. [Myelodysplastic syndromes].
Sainty D; Horschowski N; Fossat C; Sampol J
Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
[No Abstract] [Full Text] [Related]
6. Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes.
Takagi S; Tanaka O; Origasa H; Miura Y
J Clin Oncol; 1999 Jan; 17(1):277-83. PubMed ID: 10458243
[TBL] [Abstract][Full Text] [Related]
7. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
8. Myelodysplastic syndromes: natural history and features of prognostic importance.
Mufti GJ; Galton DA
Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
[No Abstract] [Full Text] [Related]
9. Clinical features of long-term survivors of refractory myelodysplastic anemias. A Japanese cooperative study.
Yoshida Y; Oguma S; Uchino H; Maekawa T; Nomura T
Leuk Res; 1992 Aug; 16(8):775-9. PubMed ID: 1528065
[TBL] [Abstract][Full Text] [Related]
10. [Clarification of possible anemia].
Uprichard J; Bain BJ
Praxis (Bern 1994); 2009 Dec; 98(24):1453-5. PubMed ID: 19953471
[No Abstract] [Full Text] [Related]
11. [The concept of and countermeasures in refractory anemia].
Yoshida Y
Nihon Naika Gakkai Zasshi; 1990 May; 79(5):593-7. PubMed ID: 2199586
[No Abstract] [Full Text] [Related]
12. [Diagnosis in the myelodysplastic syndrome].
Hunstein W; Ho AD
Dtsch Med Wochenschr; 1987 Jan; 112(2):60-2. PubMed ID: 3542464
[No Abstract] [Full Text] [Related]
13. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
14. Language and the clonal myeloid diseases.
Lichtman MA
Blood; 2002 Jan; 99(2):725-6. PubMed ID: 11799968
[No Abstract] [Full Text] [Related]
15. Myelodysplastic syndromes in childhood: description of seven cases.
Vitale A; Testi AM; Moleti ML; Vignetti M; Arcese W; Fenu S; Cedrone M; De Felice L; Amadori S; Mandelli F
Ann Hematol; 1994 May; 68(5):241-5. PubMed ID: 8018765
[TBL] [Abstract][Full Text] [Related]
16. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
Sarycheva TG; Tsvetaeva NV; Kozinets GI
Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
18. [Serum proteomics in patients with RAEB myelodysplastic syndromes].
Zhong LY; Liu TH; Li YQ; Geng SX; Lu ZS; Weng JY; Wu SJ; Luo CW; Du X
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1799-801. PubMed ID: 19778794
[TBL] [Abstract][Full Text] [Related]
19. Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome.
Tennant GB; Jacobs A
Leuk Res; 1988; 12(11-12):961-2. PubMed ID: 3216676
[TBL] [Abstract][Full Text] [Related]
20. [Myelodysplastic syndrome].
Urabe A
Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
